Generic placeholder image

Current Psychiatry Reviews

Editor-in-Chief

ISSN (Print): 1573-4005
ISSN (Online): 1875-6441

Social Anxiety Disorder - A Review of Pharmacological Treatments

Author(s): Hayley M. Robinson and Sean D. Hood

Volume 3 , Issue 2 , 2007

Page: [95 - 122] Pages: 28

DOI: 10.2174/157340007780599069

Price: $65

Abstract

Social anxiety disorder (social phobia, SAnD) is a chronic, impairing disorder characterised by embarrassment and fear relating to public scrutiny and social performance. In its generalised form it may seem to be a type of extreme shyness or variant of avoidant personality disorder and thus enduring and resistant to change. A discrete subtype has been seen as akin to simple phobia and potentially responsive to behavioural therapies. In this article we critically evaluate the pharmacological regimens that have been used to treat social anxiety disorder. An extensive search was conducted from 1980 through to June 2006. Electronic databases were used including Medline and PsycInfo using search terms including anxiety or phobia with social or treatment or therapeutics, restricted to English language manuscripts. The results of this search are presented by drug category, sorted according to both common clinical practice and strength of evidence. There are effective, well-tolerated, and powerful drug treatments of social anxiety disorder. A significant evidence base supports this assertion. Medication therapy should be considered as a first line treatment of this condition.

Keywords: Liebowitz Social Anxiety Scale, DSM-IV, Specific serotonin reuptake inhibitor, Clinical Global Impressions Improvement (CGI-I), Benzodiazepine, Neuropeptides, monoamine oxidase inhibitor


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy